PADAMOLOGY LIBRARY
Published Research
Practical insights on medical monitoring, patient safety, trial execution, and the decisions that shape early oncology development.
Accelerating the New Wave of CAR T Therapy Trials
An industry discussion exploring the evolving CAR T-cell therapy landscape and the challenges of advancing clinical trials for emerging treatments.
Phase I/II Trial of Palbociclib, Pembrolizumab, and Letrozole in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
A Phase I/II study evaluating palbociclib, pembrolizumab, and letrozole in hormone receptor-positive metastatic breast cancer.
Phase II Study of Neratinib in Older Adults with HER2 Amplified or HER2/3 Metastatic Breast Cancer
A Phase II study of neratinib in older adults with HER2-amplified or HER2/3-mutated metastatic breast cancer.
Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer
A Phase II trial evaluating pembrolizumab and enobosarm in androgen receptor-positive metastatic triple-negative breast cancer.
Older Adult Participation in Cancer Clinical Trials: A Systematic Review of Barriers and Interventions
A systematic review of barriers to older adult participation in cancer clinical trials and interventions designed to improve enrollment.
Strategies to Improve Participation of Older Adults in Cancer Research
Strategies for improving the participation and representation of older adults in cancer research.
Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists
Research examining community oncologists’ perceptions of barriers to participation in therapeutic clinical trials.
A Phase II Study of Pembrolizumab, Letrozole, and Palbociclib in Patients with Metastatic Estrogen Receptor-Positive Breast Cancer
A Phase II study investigating pembrolizumab, letrozole, and palbociclib in patients with metastatic estrogen receptor-positive breast cancer.
Barriers to Clinical Trial Enrollment of Older Adults with Cancer: A Qualitative Study of the Perceptions of Community and Academic Oncologists
A Phase II study investigating pembrolizumab, letrozole, and palbociclib in patients with metastatic estrogen receptor-positive breast cancer.